BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhandari R, Khanna G, Kuhad A. Pharmacological insight into potential therapeutic agents for the deadly Covid-19 pandemic. Eur J Pharmacol 2021;890:173643. [PMID: 33065092 DOI: 10.1016/j.ejphar.2020.173643] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Rosengarten M. Perplexity as a provocation: revisiting the role of metaphor as a ‘place holder’ for the potential of COVID-19 antibodies. Med Humanities. [DOI: 10.1136/medhum-2021-012343] [Reference Citation Analysis]
2 Chatterjee A, Saha R, Mishra A, Shilkar D, Jayaprakash V, Sharma P, Sarkar B. Molecular determinants, clinical manifestations and effects of immunization on cardiovascular health during COVID-19 pandemic era - A review. Current Problems in Cardiology 2022. [DOI: 10.1016/j.cpcardiol.2022.101250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ramanujam E, Rasikannan L., Anandhalakshmi P. A., Kamal NA. Xenobots: A Remarkable Combination of an Artificial Intelligence-Based Biological Living Robot. International Journal of Sociotechnology and Knowledge Development 2022;14:1-11. [DOI: 10.4018/ijskd.289038] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Raiten DJ, Combs GF, Steiber AL, Bremer AA. Perspective: Nutritional Status as a Biological Variable (NABV): Integrating Nutrition Science into Basic and Clinical Research and Care. Adv Nutr 2021;12:1599-609. [PMID: 34009250 DOI: 10.1093/advances/nmab046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Klassen SA, Senefeld JW, Senese KA, Johnson PW, Wiggins CC, Baker SE, van Helmond N, Bruno KA, Pirofski LA, Shoham S, Grossman BJ, Henderson JP, Wright RS, Fairweather D, Paneth NS, Carter RE, Casadevall A, Joyner MJ. Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence. Front Med (Lausanne) 2021;8:684151. [PMID: 34164419 DOI: 10.3389/fmed.2021.684151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
6 Tafler L, Danilevsky A, Seth D. Azithromycin in the Successful Management of COVID-19: A Family Physician's Perspective. Cureus 2021;13:e14574. [PMID: 34035996 DOI: 10.7759/cureus.14574] [Reference Citation Analysis]
7 Bhandari R, Khanna G, Kaushik D, Kuhad A. Divulging the Intricacies of Crosstalk Between NF-Kb and Nrf2-Keap1 Pathway in Neurological Complications of COVID-19. Mol Neurobiol 2021;58:3347-61. [PMID: 33683626 DOI: 10.1007/s12035-021-02344-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
8 Dash P, Mohapatra S, Ghosh S, Nayak B. A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review. Front Pharmacol 2020;11:590154. [PMID: 33815095 DOI: 10.3389/fphar.2020.590154] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Ashraf MU, Kim Y, Kumar S, Seo D, Ashraf M, Bae YS. COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform. Vaccines (Basel) 2021;9:171. [PMID: 33670630 DOI: 10.3390/vaccines9020171] [Cited by in Crossref: 7] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
10 Klassen S, Senefeld J, Senese K, Johnson P, Wiggins C, Baker S, van Helmond N, Bruno K, Pirofski L, Shoham S, Grossman B, Henderson J, Wright S, Fairweather D, Paneth N, Carter R, Casadevall A, Joyner M. Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence. SSRN Journal. [DOI: 10.2139/ssrn.3806768] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]